FDA clears first oral drug to treat postpartum depression or ‘baby blues’
HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 5, 2023: The USFDA has green-lighted the first oral medication indicated to treat postpartum depression in women, which occurs after.
HQ Team August 2, 2023: There is a shortage of prescription stimulant medications in the US due to a manufacturing delay by one.
HQ Team August 2, 2023: India’s Lupin Ltd., the eighth largest generic pharmaceutical company in the world based on revenue, has received the.
HQ Team July 21, 2023: Emergent BioSolutions Inc., a US developer of vaccines for infectious diseases, announced its anthrax vaccine has been approved.
HQ Team July 24, 2023: US-based Verrica Pharmaceuticals, a dermatology therapeutics company, has got FDA approval for a drug to treat a contagious.
HQ Team July 18, 2023: Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of.
HQ Team July 17, 2023: BridgeBio Pharma Inc., a Palo Alto, California-based biopharmaceutical company, reported its late-stage trial oral drug to treat a.
HQ Team July 15, 2023: Granules India Limited, an Indian vertically integrated, high-growth pharmaceutical product manufacturing company, has got the US Food &.
HQ Team July 14, 2023: The FDA has approved the first daily oral contraceptive pill, Opill, without prescription to be sold in the.
HQ Team July 11, 2023: The FDA has told e-cigarette maker Fontem US, LLC, not to market or distribute its product myblu menthol.